September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 11, 2025

"Magic Mushroom" Edibles Lack Psilocybin

Analysis of retail products reveals widespread adulteration with synthetic compounds, posing unknown health risks.

Conexiant

September 10, 2025

Prenatal Acetaminophen and ADHD/ASD: Linked?

Review of 46 human studies links prenatal acetaminophen to higher ADHD/ASD risk; evidence is heterogeneous; cohort effect sizes are generally modest but larger in some biomarker studies; authors advise cautious, short‑term use under medical guidance.

Conexiant

September 04, 2025

'No Standard of Care' for GLP-1 Weaning

Without a defined standard of care for tapering GLP-1 medications, physicians must navigate patient management amid insurer restrictions and high discontinuation rates

KFF Health News

September 04, 2025

Less TV Time May Lower Depression Risk

Compositional data analysis reveals age-specific benefits of reallocating TV-watching time to other activities, including physical activity and sleep.

Conexiant

September 01, 2025

Pain Killers

When patients are in pain, they don’t care how successful the practice’s digital marketing program is.

Compendium

August 25, 2025

Three Years Later, Still Pain-Free?

Cognitive functional therapy demonstrates durable effects on disability and pain intensity at 3 years, with outcomes remaining stable beyond the 12-month mark in patients with chronic low back pain

Conexiant

August 19, 2025

‘Enough Is Enough’—But When?

How Bogalusa, Louisiana became a lens on the US gun violence epidemic—where race, poverty, policy, and profit converge and communities bear the cost.

KFF Health News

August 19, 2025

Bedtime Cyclobenzaprine Relieves Fibromyalgia: Randomized Trial

Researchers found bedtime sublingual cyclobenzaprine reduced pain versus placebo and improved sleep, fatigue, and function with mostly mild oral adverse events.

Conexiant